Recent news, events and Podcasts

Latest Breakthroughs in Alzheimer’s Research

Stay informed with the latest advancements and significant findings in Alzheimer’s disease research, including groundbreaking studies and new treatment opportunities.

'Global first' Alzheimer’s study calling for participants - ABC Radio

16 Oct 2024

A global first Alzheimer’s study needs trial participants. Professor John Mamo from Curtin University and the Perron Institute for Neurological and Translational Science explained who is eligible for the trial.

Distinguished health scientist, John Mamo joins Perron Institute

19 Oct 2023

The Perron Institute’s capability in neurosciences has been further strengthened by the appointment of John Curtin Distinguished Professor John Mamo to facilitate translational research on Alzheimer’s disease and other neurological disorders.

John Mamo Nominated for Scientist of the Year

20 JUL 2023

Professor John Mamo is a finalist for Scientist of the Year at the 2023 Premier’s Science Awards, recognised for his pioneering Alzheimer’s research and global impact.

New Curtin research identifies likely cause of Alzheimer’s disease

14 SEP 2021

Groundbreaking research identifies a likely cause of Alzheimer’s disease, opening avenues for new prevention and treatment options for Australia’s second-leading cause of death.

John Mamo Named John Curtin Distinguished Professor

26 FEB 2021

Professor John Mamo has been named John Curtin Distinguished Professor for his pioneering Alzheimer's research, highlighting his dedication to advancing neurological science and improving patient outcomes.

Alzheimer's research project awarded NHMRC funding

15 Dec 2020

A $637,536 Federal grant will fund research led by Professor John Mamo to explore new Alzheimer's treatments. The project investigates how a liver protein may damage brain blood vessels, potentially leading to early onset Alzheimer's.

Innovative Alzheimer's Treatment Receives $1.72 Million in Funding

27 JUN 2020

Professor John Mamo's research project has received $1.72 million to trial a new Alzheimer's treatment. The drug aims to prevent brain capillary leakage and inflammation, potentially improving cognitive function in patients.

Events

Join us for informative sessions on Alzheimer’s research, meet our experts, and stay updated on the latest breakthroughs. Browse our past events below and check back for future opportunities.

Have a Go Day – Chat with the PIA Perth Clinical Trial Team

13 NOV 2024

Join us at Have a Go Day, a LiveLighter event dedicated to promoting exercise, socialisation, and mental activity for the over-55s. Come by our marquee to chat with the PIA Perth Study clinical trial team and learn more about Alzheimer’s prevention and treatment options.

Past Event

Pro-Alzheimer's Clinical Trial Information Session

16 SEP 2024

We hosted an information session at Manning Community Centre, sharing insights on Alzheimer's prevention and treatment. Attendees enjoyed a presentation, Q&A with experts, and a meet-and-greet.

Listen Now

Podcasts

Listen to our podcasts for our expert in-depth discussions and insights.

More Information

Media & Scientific Enquiries

For media enquiries or to discuss the PIA Study with our research team, please reach out.